Emilio Guirao‐Arrabal

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection

José Luís Callejas Rubio, Juan de Dios Luna del Castillo, Javier de la Hera Fernández et al. · Medicina Clínica (English Edition) · 2020 · 57 citations · Full text

Sars-cov-2 Infection, Immunodeficiencies, Covid-19 Pandemic +7

Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of m<scp>TOR</scp> inhibitors and azathioprine use

Emilio Guirao‐Arrabal, F. Santos, Javier Redel‐Montero et al. · Transplant Infectious Disease · 2016 · 40 citations

Efficacy and safety of short‐term treatment with isoniazid and rifampicin for latent tuberculosis infection in lung transplant candidates

Emilio Guirao‐Arrabal, F. Santos, Javier Redel et al. · Clinical Transplantation · 2016 · 15 citations

Lung Ultrasound, Clinical and Analytic Scoring Systems as Prognostic Tools in SARS-CoV-2 Pneumonia: A Validating Cohort

Jaime Gil-Rodríguez, Michel Martos-Ruíz, José-Antonio Peregrina-Rivas et al. · Diagnostics · 2021 · 13 citations · Full text

Prognosis, Diagnosis, Thoracic Ultrasound +24